Nordic Nanovector ASA announced that Ludvik Sandnes, former Chairperson of Nordic Nanovector, has been appointed interim Chief Executive Officer (CEO) of the Company as from 1 February 2023. Ludvik Sandnes will no more attend the Oncoinvent Board. Malene Brondberg, current interim CEO, will transition out of the Company, as previously announced on 9 December 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 NOK | +2.74% | +5.11% | -18.60% |
06-26 | Thor Medical Gets Clearance for Medical Isotope Production in Norway | MT |
06-06 | Thor Medical Partners With Steenkampskraal for Thorium Feedstock Supply | MT |
1st Jan change | Capi. | |
---|---|---|
-18.60% | 23.14M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- NANOV Stock
- News Thor Medical
- Nordic Nanovector ASA Announces CEO Changes